Menu
  • Join
  • Login
  • Contact
 

Search abstracts


Analysis on reasons for discontinuation of sglt2i in type 2 diabetes mellitus patients in taiwan

  • At: 2018 FIP Congress in Glasgow (Scotland)
  • Type: Poster
  • By: LIN, Yi-Han (Chang Gung Memorial Hospital, Keelung, Taiwan, Department of Pharmacy)
  • Co-author(s): Yi-Han Lin: Department of Pharmacy, Chang Gung Memorial Hospital, Keelung, Taiwan, Keelung city, Taiwan, Province of China
    Shih-Chieh Shao: Department of Pharmacy, Chang Gung Memorial Hospital, Keelung, Taiwan, Keelung city, Taiwan, Province of China;School of Pharmacy, Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan city, Taiwan, Province of China
    Yuk-Ying Chan: Department of Pharmacy, Linkou Chang Gung Memorial Hospital, Taoyuan, Taiwan, Province of China
    Hui-Yu Chen: Department of Pharmacy, Chang Gung Memorial Hospital, Keelung, Taiwan, Keelung city, Taiwan, Province of China
  • Abstract:

    Background

    Adherence on glucose co-transporter 2 inhibitors (SGLT2i) is the primary issue for type 2 diabetes mellitus (T2DM) patients in real-world settings. Understanding the reasons for discontinuations is crucial for successful strategies to improve treatment outcome.

    Methods

    We conducted a cohort study and analyzed the data of three hospitals in

    ..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses